Skip to main content

Table 1 Baseline data of neuroendocrine differentiated colorectal cancer patients

From: Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infiltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p

Factors

No. Patients

\({\chi }^{2}\)/\(U\)

\({\rm P}\)

Total

Percentage (%)

NED

Non-NED

All patients

105

100.0

18

87

  

Gender

    

1.559a

0.212

  Male

62

59.0

13

49

  

  Female

43

41.0

5

38

  

Age

    

724.5b

0.498

  ≤ 50

24

22.9

3

21

  

  > 50

81

77.1

15

66

  

Primary tumor site

    

0.303a

0.582

  Colon

58

55.2

11

47

  

  Rectum

47

44.8

7

40

  

Tumor differentiation

    

736.5b

0.593

  High

18

17.1

3

15

  

  Moderate

81

77.1

13

68

  

  Low

6

5.7

2

4

  

TNM stage

    

724.5b

0.603

  I

13

12.4

3

10

  

  II

34

32.4

4

30

  

  III

42

40.0

7

35

  

  IV

16

15.2

4

12

  

Lymphatic metastasis

    

0.043a

0.836

  Positive

56

53.3

10

46

  

  Negative

49

46.7

8

41

  

Simultaneous distant metastasis

    

0.298c

0.585

  Yes

16

15.2

4

12

  

  No

89

84.8

14

75

  
  1. NED Neuroendocrine differentiation group, non-NED Non-neuroendocrine differentiation group
  2. a The chi-square test, \({\chi }^{2}\)
  3. b The Mann–Whitney U rank-sum test, \(U\)
  4. c The chi-square test with Yates’ correction, \({\chi }^{2}\)